KMB · Kimberly Clark Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $16.45B | $20.06B | $20.43B | $20.18B | $19.44B | $19.14B |
| Cost of Revenue | $10.52B | $12.88B | $13.40B | $13.96B | $13.45B | $12.32B |
| Gross Profit | $5.92B | $7.18B | $7.03B | $6.22B | $5.99B | $6.82B |
| R&D | $326.00M | $338.00M | $312.00M | $292.00M | $269.00M | $276.00M |
| SG&A | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $805.00M | $781.00M | $753.00M | $754.00M | $766.00M | $796.00M |
| Operating Income | $2.35B | $3.21B | $2.34B | $2.68B | $2.56B | $3.24B |
| Interest Expense | $256.00M | $270.00M | $293.00M | $282.00M | $256.00M | $252.00M |
| Income Tax | $599.00M | $565.00M | $453.00M | $495.00M | $479.00M | $676.00M |
| Net Income | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B | $2.35B |
| EPS - Basic | $6.09 | $7.58 | $5.22 | $5.73 | $5.38 | $6.90 |
| EPS - Diluted | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 | $6.87 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $688.00M | $1.02B | $1.09B | $427.00M | $270.00M | $303.00M |
| Accounts Receivable | $1.89B | $2.01B | $2.13B | $2.28B | $2.21B | $2.23B |
| Inventory | $1.48B | $1.82B | $1.96B | $2.27B | $2.24B | $1.90B |
| Accounts Payable | $3.39B | $3.71B | $3.65B | $3.81B | $3.84B | $3.34B |
| Current Assets | $5.31B | $5.58B | $5.70B | $5.73B | $5.57B | $5.17B |
| Total Assets | $17.10B | $16.55B | $17.34B | $17.97B | $17.84B | $17.52B |
| Current Liabilities | $7.13B | $7.00B | $6.93B | $7.33B | $6.75B | $6.44B |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - |
| Stockholders' Equity | $1.50B | $840.00M | $915.00M | $547.00M | $514.00M | $626.00M |
| Retained Earnings | $9.61B | $9.26B | $8.37B | $8.20B | $7.86B | $7.57B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.78B | $3.23B | $3.54B | $2.73B | $2.73B | $3.73B |
| Investing Cash Flow | ($951.00M) | ($100.00M) | ($418.00M) | ($785.00M) | ($1.06B) | ($2.31B) |
| Financing Cash Flow | ($2.18B) | ($3.17B) | ($2.37B) | ($1.76B) | ($1.70B) | ($1.57B) |
| CapEx | $1.14B | $721.00M | $766.00M | $876.00M | $1.01B | $1.22B |
| Free Cash Flow | $1.64B | $2.51B | $2.78B | $1.86B | $1.72B | $2.51B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 36.0% | 35.8% | 34.4% | 30.8% | 30.8% | 35.6% |
| Operating margin | 14.3% | 16.0% | 11.5% | 13.3% | 13.2% | 16.9% |
| EBITDA margin | 19.2% | 19.9% | 15.2% | 17.0% | 17.1% | 21.1% |
| Net margin | 12.3% | 12.7% | 8.6% | 9.6% | 9.3% | 12.3% |
| Free cash flow margin | 10.0% | 12.5% | 13.6% | 9.2% | 8.9% | 13.1% |
| FCF / Net income | 0.81 | 0.99 | 1.57 | 0.96 | 0.95 | 1.07 |
| R&D / Revenue | 2.0% | 1.7% | 1.5% | 1.4% | 1.4% | 1.4% |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | 22.9% | 18.2% | 20.4% | 20.4% | 20.9% | 22.3% |
| Return on assets | 11.8% | 15.4% | 10.2% | 10.8% | 10.2% | 13.4% |
| Return on equity | 134.6% | 303.0% | 192.8% | 353.6% | 352.9% | 375.7% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 0.75 | 0.80 | 0.82 | 0.78 | 0.82 | 0.80 |
| Quick ratio | 0.54 | 0.54 | 0.54 | 0.47 | 0.49 | 0.51 |
| Cash ratio | 0.10 | 0.15 | 0.16 | 0.06 | 0.04 | 0.05 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 9.2x | 11.9x | 8.0x | 9.5x | 10.0x | 12.9x |
| Equity multiplier | 11.38 | 19.70 | 18.96 | 32.85 | 34.70 | 27.99 |
| Liabilities / Assets | - | - | - | - | - | - |
| Efficiency | ||||||
| Asset turnover | 0.96 | 1.21 | 1.18 | 1.12 | 1.09 | 1.09 |
| Inventory turnover | 7.13 | 7.07 | 6.85 | 6.15 | 6.01 | 6.47 |
| Days sales outstanding | 42d | 37d | 38d | 41d | 41d | 43d |
| Days inventory outstanding | 51d | 52d | 53d | 59d | 61d | 56d |
| Days payable outstanding | 118d | 105d | 100d | 100d | 104d | 99d |
| Cash conversion cycle | -24d | -17d | -8d | 1d | -2d | 0d |
| Valuation | ||||||
| P / E | 16.6x | 17.4x | 23.3x | 23.7x | 26.7x | 19.6x |
| P / B | 22.4x | 52.6x | 45.0x | 84.0x | 94.2x | 73.8x |
| P / S | 2.0x | 2.2x | 2.0x | 2.3x | 2.5x | 2.4x |
| EV / EBITDA | 10.4x | 10.8x | 12.9x | 13.2x | 14.5x | 11.4x |
| Growth | ||||||
| Revenue growth (YoY) | -18.0% | -1.8% | 1.3% | 3.8% | 1.6% | 4.3% |
| Revenue CAGR (3y) | -6.6% | 1.0% | 2.2% | 3.2% | 1.7% | 1.6% |
| Revenue CAGR (5y) | -3.0% | 1.8% | 2.0% | 2.0% | 1.3% | 0.6% |
| Gross profit growth (YoY) | -17.5% | 2.1% | 13.1% | 3.9% | -12.2% | 13.0% |
| Operating income growth (YoY) | -26.8% | 36.9% | -12.6% | 4.7% | -21.1% | 8.5% |
| Net income growth (YoY) | -20.6% | 44.3% | -8.8% | 6.6% | -22.9% | 9.0% |
| EPS growth (YoY) | -19.6% | 44.9% | -8.9% | 6.9% | -22.1% | 10.1% |
| EPS CAGR (3y) | 2.0% | 12.2% | -8.8% | -2.9% | 9.9% | 2.4% |
| EPS CAGR (5y) | -2.4% | 3.9% | 5.3% | -2.2% | -2.2% | 19.9% |
| FCF growth (YoY) | -34.8% | -9.5% | 49.5% | 7.8% | -31.4% | 64.5% |
| FCF CAGR (5y) | -8.2% | 10.5% | 5.8% | -5.4% | -6.9% | 15.0% |
| Book value growth (YoY) | 78.8% | -8.2% | 67.3% | 6.4% | -17.9% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$16.45B totalNorth America NA$10.75B · 65.4%
International Personal Care IPC$5.69B · 34.6%
Product / service
$16.45B totalBabyandchildcareproducts$6.77B · 41.2%
Family Care$4.06B · 24.7%
Adult Care Products$1.95B · 11.8%
Professional$1.84B · 11.2%
Feminine Care Products$1.71B · 10.4%
All Other$124.00M · 0.8%
Geographic
$10.10B totalUS$10.10B · 100.0%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Converted Paper & Paperboard Prods (No Contaners/Boxes)
Comparing KIMBERLY CLARK CORP against the 3 most active filers in the same SIC group.
Dividends
$5.06/share trailing 12 months · +2.8% YoY
| Ex-date | Per share |
|---|---|
| Mar 6, 2026 | $1.2800 |
| Dec 5, 2025 | $1.2600 |
| Sep 5, 2025 | $1.2600 |
| Jun 6, 2025 | $1.2600 |
| Mar 7, 2025 | $1.2600 |
| Dec 6, 2024 | $1.2200 |
| Sep 6, 2024 | $1.2200 |
| Jun 7, 2024 | $1.2200 |
| Mar 7, 2024 | $1.2200 |
| Dec 7, 2023 | $1.1800 |
| Sep 7, 2023 | $1.1800 |
| Jun 8, 2023 | $1.1800 |
| Mar 9, 2023 | $1.1800 |
| Dec 8, 2022 | $1.1600 |
| Sep 8, 2022 | $1.1600 |
| Jun 9, 2022 | $1.1600 |
| Mar 3, 2022 | $1.1600 |
| Dec 9, 2021 | $1.1400 |
| Sep 9, 2021 | $1.1400 |
| Jun 3, 2021 | $1.1400 |
| Mar 4, 2021 | $1.1400 |
| Dec 3, 2020 | $1.0700 |
| Sep 3, 2020 | $1.0700 |
| Jun 4, 2020 | $1.0700 |